This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Ingelheim (Canada) Ltd.. Active years: 2001-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Vimontl, CA (2001)
- Vimont, CA (2004)
Company Filing History:
Years Active: 2001-2004
Title: The Innovations of Marc-André Poupart
Introduction
Marc-André Poupart is a notable inventor based in Vimont, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of hepatitis C inhibitor peptides. With a total of 2 patents to his name, Poupart's work is recognized for its potential impact on medical treatments.
Latest Patents
Among his latest patents are innovative compounds aimed at combating hepatitis C. These include "Hepatitis C inhibitor peptides" and "Hepatitis C inhibitor tri-peptides," which focus on a racemate, diastereoisomer, and optical isomer of a compound of formula (I). These advancements showcase his dedication to addressing critical health issues.
Career Highlights
Marc-André Poupart is currently employed at Boehringer Ingelheim (Canada) Ltd., where he continues to push the boundaries of pharmaceutical research. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Montse Llinas-Brunet and Murray D Bailey. Their collective expertise contributes to the innovative environment at Boehringer Ingelheim, fostering advancements in medical science.
Conclusion
Marc-André Poupart's contributions to the field of pharmaceuticals, particularly in hepatitis C research, highlight his role as a significant inventor. His ongoing work promises to lead to further innovations that could benefit many in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile